- Market cap
- Revenue
- Net income
- Cash on hand
- Gross margin
- Net margin
- EPS
- P/E ratio
Mr. Stansky was a Managing Director of Tudor Investment Corporation where he was responsible for long/short equity, crossover, and venture capital investments. He helped establish Tudor’s equity investment group in 1994 and retired from active investment management in 2008. From …
David Patience was appointed Chief Financial Officer beginning in July 2025. David has nearly 20 years of experience as a financial executive across healthcare and financial services. Prior to TriSalus, David served as Chief Financial Officer at Accelerate Diagnostics. David …
Dr Richard Marshall was appointed as Medical Director in January 2025. Dr. Marshall is an Interventional Radiologist who continues to have an active outpatient and inpatient practice. After graduating from Tulane University School of Medicine, he completed his residency at …
An accomplished pharmaceutical executive and strategic business leader, Dr. Gordon has extensive experience in the development of drugs from first in-human studies to approval and commercialization. Dr. Gordon brings innovative approaches to the process, leveraging advantageous regulatory pathways and close …
William “Bill” Valle is the Executive Chairman of Compassus, a leading provider of hospice, home health, palliative, and infusion services, and serves on the board of directors of American Oncology Network, a community-based oncology company. He has held both roles …
Mary Szela has nearly 35 years of experience driving growth and creating value for patients and investors in both the commercial and clinical pharmaceutical arenas. Mary has served as CEO and President of TriSalus Life Sciences since January 2018. Prior …
Dr. Richard Marshak was appointed Chief Commercial Officer in January 2025. Previously he served as Senior Vice President, Corporate Development, Strategy, and Marketing at TriSalus since June 2022. Previously, Dr. Marshak was Managing Principal of LF Consulting, a consulting firm …
Jennifer Stevens has been the Chief Regulatory Officer at TriSalus since March 2022 and served as TriSalus’ Senior Vice President of Regulatory Affairs from March 2021 to March 2022. Previously, Jennifer held several progressive leadership roles with EMD Serono Inc., …
David served as the Chief Financial Officer and director of MTAC’s since September 2020. David was also the co-founder and Chief Executive Officer of MatlinPatterson Global Advisers LLC (“MatlinPatterson”), a distressed securities investment manager, which he co-founded in July 2002, …
New data from PERIO-01 clinical trial indicates PEDD™ method resulted in modulation of the tumor microenvironment and decreased circulating tumor DNA (ctDNA) levels DENVER and CHICAGO, June 12, 2023 – TriSalus Life Sciences® Inc., (TriSalus or the Company), an oncology …
